Research Topics
| S E PurdonSummaryAffiliation: Phoenix Program Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Asymmetrical hand force persistence and neuroleptic treatment in schizophreniaS E Purdon
The University of Alberta and The Alberta Hospital Edmonton, Canada
J Int Neuropsychol Soc 7:606-14. 2001....
Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophreniaS E Purdon
University of Alberta and Alberta Hospital, Edmonton, Canada
Arch Gen Psychiatry 57:249-58. 2000..The purpose of this investigation was to test the efficacy of novel antipsychotic medications in the treatment of cognitive impairment in early phase schizophrenia...
Asymmetrical olfactory acuity and neuroleptic treatment in schizophreniaS E Purdon
Alberta Hospital Edmonton, Box 307, Edmonton, T5J 2J7, Alberta, Canada
Schizophr Res 44:221-32. 2000..Results are discussed in relation to cerebral aspects of schizophrenia and potential implications to cognitive change from treatment...
Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidolScot E Purdon
Department of Psychiatry, University of Alberta, CHA ANE, Box 307, Edmonton, Alberta, Canada T5J 2J7
Psychopharmacology (Berl) 169:390-7. 2003..Olanzapine is pharmacologically similar to clozapine and has a low incidence of EPS induction...
Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidolS E Purdon
University of Alberta, Edmonton, Alta
J Psychiatry Neurosci 26:137-49. 2001..To assess the efficacy of quetiapine, a recently introduced second generation antipsychotic medication, in reducing cognitive impairment in patients with schizophrenia...
Menstrual effects on asymmetrical olfactory acuityS E Purdon
Department of Psychiatry, University of Alberta, Edmonton, Canada
J Int Neuropsychol Soc 7:703-9. 2001....
Cognitive improvement in schizophrenia with novel antipsychotic medicationsS E Purdon
Neuropsychology, Alberta Hospital Edmonton, Alb, Canada
Schizophr Res 35:S51-60. 1999....
Neuropsychological change in schizophrenia after 6 weeks of clozapineS E Purdon
Department of Psychiatry, University of Alberta, Alberta, Edmonton, Canada
Schizophr Res 48:57-67. 2001....
An fMRI investigation of procedural learning in unaffected siblings of individuals with schizophreniaNeil D Woodward
Department of Psychology, Vanderbilt University, Nashville, TN 37203, USA
Schizophr Res 94:306-16. 2007..Identification of genes related to the function of cerebral regions such as the prefrontal cortex, parietal lobe, and basal ganglia may assist in delineating the genetic contributions to schizophrenia...
A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effectsNeil D Woodward
Department of Psychology, Vanderbilt University, 301 Wilson Hall, 111 21st Ave S, Nashville, TN 37203, USA
Schizophr Res 89:211-24. 2007....
One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophreniaRichard S E Keefe
Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC 27710, USA
Schizophr Res 81:1-15. 2006..Haloperidol-treated patients improved only on domains of learning/memory. However, patients able to remain in treatment for the entire 52 weeks benefited more from olanzapine or risperidone treatment than haloperidol treatment...
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophreniaNeil D Woodward
Department of Psychology, Vanderbilt University, Nashville, TN 37203, USA
Int J Neuropsychopharmacol 8:457-72. 2005..Atypical antipsychotics produce a mild remediation of cognitive deficits in schizophrenia, and specific atypicals have differential effects within certain cognitive domains...
Procedural learning in schizophrenia investigated with functional magnetic resonance imagingLenka Zedkova
Department of Psychiatry and Bebensee Schizophrenia Research Unit, University of Alberta, Edmonton, Alberta, Canada
Schizophr Res 88:198-207. 2006..The results are thus consistent with a neurodevelopmental pathology impinging on fronto-subcortical circuitry...
[A brief scale to assess cognitive impairment in psychiatric patients]Oscar Pino
Hospital Universitario de Bellvitge
Psicothema 18:447-52. 2006..There is also a language effect that may be due to sample and/or cultural characteristics. Finally, in both versions intra-class correlation coefficients and factorial structure are very similar...
Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophreniaOscar Pino
Department of Psychiatry, Hospital General Granollers Benito Menni CASM, Granollers, Barcelona, Spain
Schizophr Res 99:139-48. 2008..This study examined the psychometric properties of the Spanish version of the SCIP in a sample of outpatients suffering schizophrenia-spectrum disorders...
Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophreniaScot E Purdon
Bebensee Schizophrenia Research Unit, Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada
Schizophr Res 99:218-24. 2008..Elevated glutamate may relate to poor sustained attention and elevated risk of schizophrenia, suggesting a potential role for glutamate in an endophenotype for schizophrenia...
